NASDAQ · LUCYW

Innovative Eyewear, Inc.. 8/16/27

$0.03 -$0.02 (-47.16%) 1D Market open

Key Metrics

$61.58K
Market cap
P/E · TTM
$2.98M
Revenue · TTM
−$8.12M
Net income
EPS · TTM $-3.31
Dividend yield
Free cash flow −$7.53M
Beta · 1Y 0.19
EBITDA · TTM
Gross margin 17.5%

The Story So Far

LAST 6 MONTHS PRIMARY SOURCES ONLY
  • Jul 16
    Money rotated out of high-beta cohorts market-wide.

    High-beta names lagged the blue-chips by 20.3 points over ten sessions around this date. Stocks in that cohort weren't falling alone — they fell together.

    RECEIPT: ROTATION GAUGE, LIVE
  • Jun 30
    The stock moved +55.2% in a single session.

    Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.

    RECEIPT: DAILY BAR, Jun 30
  • Jun 25
    The stock moved +68.9% in a single session.

    Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.

    RECEIPT: DAILY BAR, Jun 25
  • Jun 24
    From its Feb 23 high, the share price fell 68%.

    Peak close $0.08 on Feb 23; trough close $0.03 on Jun 24. The drawdown is the fact — the chapters around it are the context.

    RECEIPT: PRICE SERIES, PEAK-TO-TROUGH -68%

The story updates itself as events post · The wolf reports; you decide

Snapshot

Market cap
Enterprise value
Shares outstanding
52-wk range$0.03 – $0.18
Avg volume · 20D14.9K
Net cash
Book value / share$3.41
IndustryOphthalmic Goods
ExchangeNASDAQ
About Innovative Eyewear, Inc.. 8/16/27
IPO dateApr 27, 2022
Employees13

Innovative Eyewear Inc is engaged in developing and selling eyeglasses and sunglasses, which are designed to allow customers to remain connected to their digital lives, while also offering prescription eyewear and sun protection.

Wolf Grade COMING SOON

The wolf is in training. Composite grades vs sector — profitability, health, value, momentum — arrive with the percentile engine. Methodology will be public.

Valuation

P/E
P/S0.02
P/FCF
EV/EBITDA
EV/Sales
Graham №

Profitability

Gross 17.5%
Operating
Net -272.5%
FCF -252.5%
ROE / ROIC -93.0% · —

Financial Health

Current ratio8.02
Quick ratio6.73
Debt / equity
Debt / EBITDA
Net cash
Working capital$7.66M

Cash Flow · TTM

Operating CF −$7.45M
Capex −$72.51K
Free cash flow −$7.53M
Buybacks
Dividends paid
Shareholder yield

Piotroski F-Score

4 / 9
Middling fundamentals · 4 of 9 signals passing

Altman Z-Score

Insufficient balance-sheet inputs

Graham Number vs Price

Requires positive earnings and book value
Fundamentals through 2026-03-31 · computed by TickerWolf from SEC filings